Kaleido Biosciences, Inc

(NASDAQ:KLDO)

Latest On Kaleido Biosciences, Inc (KLDO):

Date/Time Type Description Signal Details
2022-04-08 17:02 ESTNewsKaleido Biosciences to delist from Nasdaq as business operations endN/A
2022-01-31 03:10 ESTNewsKaleido Bio discontinues Phase 2 KB109 study, ends collaboration with COPD FoundationN/A
2021-12-08 08:28 ESTNewsKaleido Biosciences (KLDO) Investor Presentation - SlideshowN/A
2021-11-10 10:35 ESTNewsKaleido Biosciences picked industry veteran as chief medical officerN/A
2021-11-01 22:03 ESTNewsKaleido Biosciences EPS misses by $0.02, misses on revenueN/A
2021-10-19 13:33 ESTNewsKaleido hits a 52-week low as Morgan Stanley downgrades on lack of catalystsN/A
2021-10-13 03:13 ESTNewsWarning: KLDO is at high risk of performing badlyN/A
2021-10-06 11:02 ESTNewsKLDO is at high risk of performing badlyN/A
2021-10-06 10:49 ESTNewsKaleido shares topline data from non-IND study for ulcerative colitis candidateN/A
2021-10-06 10:46 ESTNewsSmall Kaleido ulcerative colitis study fails to impress investors as shares declineN/A
2021-09-27 20:05 ESTNewsWarning: KLDO has been downgraded to Very BearishN/A
2021-09-21 22:12 ESTNewsWarning: KLDO has been downgraded to Very Bearish.N/A
2021-08-11 23:03 ESTNewsKaleido Biosciences EPS beats by $0.01, beats on revenueN/A
2021-08-11 03:17 ESTNewsKaleido Biosciences and COPD Foundation ink strategic collaboration to study KB109N/A
2021-07-21 13:23 ESTNewsSCOR, GOGL, KLDO and APM among after-hours moversN/A
2021-07-21 13:13 ESTNewsKaleido Biosciences appoints Jerald Korn as Chief Operating OfficerN/A
2021-05-04 21:58 ESTNewsKaleido Biosciences EPS misses by $0.01N/A
2021-03-24 20:32 ESTNewsKaleido Bio's KB109 shows positive effect in COVID-19 symptomsN/A
2021-03-18 21:12 ESTNewsOur First Look At Kaleido BiosciencesN/A
2021-03-10 11:47 ESTAnalyst RatingThe Analyst Target Price has decreased from $15.71 to $15.57.Neutral
2021-03-05 11:51 ESTAnalyst RatingThe Analyst Target Price has decreased from $15.93 to $15.71.Neutral
2021-03-04 11:56 ESTEarnings EstimateAn EPS average of -$2.55 is estimated for the 2022 year.Sell
2021-03-04 11:56 ESTEarnings EstimateAn EPS average of -$0.51 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-04 03:58 ESTFinancialsCompany financials have been released.Neutral
2021-03-03 08:59 ESTNewsKaleido Biosciences EPS beats by $0.11N/A
2021-03-01 19:28 ESTNewsKaleido Bio CEO discloses company positionN/A
2021-02-12 02:52 ESTNewsUnderwriters exercise option for additional shares in Kaleido public offeringN/A
2021-02-10 07:55 ESTAnalyst RatingThe Analyst Target Price has increased from $15.42 to $15.93.Buy
2021-02-03 21:14 ESTNewsKaleido Biosciences announces $50M proposed public offeringN/A
2021-01-21 12:05 ESTAnalyst RatingThe Analyst Target Price has increased from $14.58 to $15.42.Buy
2021-01-15 07:59 ESTAnalyst RatingThe Analyst Target Price has increased from $13.33 to $14.58.Buy
2021-01-14 21:41 ESTNewsKaleido Bio's KB109 shows benefit in COVID-19 studyN/A
2021-01-06 15:59 ESTFinancialsCompany financials have been released.Neutral
2021-01-04 11:21 ESTNewsKaleido concludes enrollment in KB109 study in COVID-19N/A
2020-12-25 08:20 ESTAnalyst RatingThe Analyst Target Price has increased from $11.6 to $13.33.Buy
2020-11-26 20:37 ESTFinancialsCompany financials have been released.Neutral
2020-11-12 04:24 ESTAnalyst RatingThe Analyst Target Price has decreased from $12.4 to $11.6.Neutral
2020-11-07 16:16 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 20:09 ESTFinancialsCompany financials have been released.Neutral
2020-11-05 08:10 ESTAnalyst RatingThe Analyst Target Price has decreased from $12.6 to $12.4.Neutral
2020-11-03 08:20 ESTEarnings EstimateAn EPS average of -$0.46 is estimated for the quarter ending on March 31, 2021.Buy
2020-10-30 13:38 ESTAnalyst RatingThe Analyst Target Price has decreased from $13.25 to $12.6.Neutral
2020-10-06 15:03 ESTNewsKaleido extends timeline for data readout on KB109 in COVID-19N/A
2020-10-01 15:55 ESTNewsWhy Kaleido Stock Is Taking Off, And Why It Can Go HigherN/A
2020-10-01 15:55 ESTNewsKaleido Biosciences appoints Daniel Menichella as President and CEON/A
2020-09-30 08:29 ESTNewsDosing underway in study of Kaleido Biosciences' KB295 in ulcerative colitisN/A
2020-09-26 13:12 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:19 ESTFinancialsCompany financials have been released.Neutral
2020-08-23 04:13 ESTNewsStocks To Watch: Spotlight On Palo Alto Networks, Best Buy And Xpeng MotorsN/A
2020-08-14 09:15 ESTFinancialsCompany financials have been released.Neutral

About Kaleido Biosciences, Inc (KLDO):

Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of immuno-oncology, and cardiometabolic and liver diseases. The company has collaboration agreements with Gustave Roussy Cancer Center, Washington University School of Medicine, and Janssen. The company was incorporated in 2015 and is headquartered in Lexington, Massachusetts.

KLDO Quotes by TradingView

See Advanced Chart

General

  • Name Kaleido Biosciences, Inc
  • Symbol KLDO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 82
  • Fiscal Year EndDecember
  • IPO Date2019-02-28
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://kaleido.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 344.11
  • Price/Book (Most Recent Quarter) 20.78
  • Enterprise Value Revenue 425.81
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.39
  • Next Year EPS Estimate -$2.18
  • Next Quarter EPS Estimate -$0.48
  • Operating Margin -8090%
  • Return on Assets -70%
  • Return on Equity -235%
  • Revenue 975000
  • Earnings Per Share -$6.24
  • Revenue Per Share $0.03
  • Gross Profit -54992000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 438.26 million
  • EBITDA -82607000
  • Analyst Target Price $15.57
  • Book Value Per Share $0.57
View More

Share Statistics

  • Shares Outstanding 42.47 million
  • Shares Float 20.72 million
  • % Held by Insiders 503%
  • % Held by Institutions 79.77%
  • Shares Short 2.6 million
  • Shares Short Prior Month 2.76 million
  • Short Ratio 5.92
  • Short % of Float 12%
  • Short % of Shares Outstanding 6%
View More

Technicals

  • Beta -0.27
  • 52 Week High $16.93
  • 52 Week Low $4.55
  • 50 Day Moving Average 10.96
  • 200 Day Moving Average 9.1
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Kaleido Biosciences, Inc (KLDO) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Kaleido Biosciences, Inc (KLDO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-03$243000-$0.56-$0.40-40.56%
2020-09-302020-11-02$482000-$0.65-$0.63-2.39%
2020-06-302020-08-04$250000-$0.59-$0.590%
2020-03-312020-05-14$N/A-$0.64-$0.640.23%
2019-12-312020-03-02$N/A-$0.65-$0.34-93.11%
2019-09-302019-10-30$N/A-$0.74-$0.9017.38%
2019-06-302019-08-01$N/A-$0.83-$1.0016.8%
2019-03-312019-05-02$N/A-$0.68-$0.748.17%

Kaleido Biosciences, Inc (KLDO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Kaleido Biosciences, Inc (KLDO) Chart:

Kaleido Biosciences, Inc (KLDO) News:

Below you will find a list of latest news for Kaleido Biosciences, Inc (KLDO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Kaleido Biosciences, Inc (KLDO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Kaleido Biosciences, Inc (KLDO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000120919120039730/0001209191-20-039730-index.htm
2018-10-24UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1751299/000000000018033252/0000000000-18-033252-index.htm
2018-11-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1751299/000000000018035023/0000000000-18-035023-index.htm
2018-11-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1751299/000000000018036381/0000000000-18-036381-index.htm
2019-02-22UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1751299/000000000019002984/0000000000-19-002984-index.htm
2020-03-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1751299/000000000020002051/0000000000-20-002051-index.htm
2020-08-12UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1751299/000000000020007375/0000000000-20-007375-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1751299/000031506620001097/0000315066-20-001097-index.htm
2019-02-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319005055/0000899243-19-005055-index.htm
2019-02-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319005057/0000899243-19-005057-index.htm
2019-02-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319005058/0000899243-19-005058-index.htm
2019-02-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319005061/0000899243-19-005061-index.htm
2019-02-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319005063/0000899243-19-005063-index.htm
2019-02-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319005066/0000899243-19-005066-index.htm
2019-02-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319005068/0000899243-19-005068-index.htm
2019-02-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319005070/0000899243-19-005070-index.htm
2019-02-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319005071/0000899243-19-005071-index.htm
2019-02-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319005074/0000899243-19-005074-index.htm
2019-02-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319005075/0000899243-19-005075-index.htm
2019-02-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319005076/0000899243-19-005076-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319005957/0000899243-19-005957-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319005958/0000899243-19-005958-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319005960/0000899243-19-005960-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319005963/0000899243-19-005963-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319005964/0000899243-19-005964-index.htm
2019-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319006452/0000899243-19-006452-index.htm
2019-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319006455/0000899243-19-006455-index.htm
2019-07-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319019981/0000899243-19-019981-index.htm
2019-07-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319020104/0000899243-19-020104-index.htm
2019-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319020827/0000899243-19-020827-index.htm
2019-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319020828/0000899243-19-020828-index.htm
2019-10-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319024670/0000899243-19-024670-index.htm
2019-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319024676/0000899243-19-024676-index.htm
2019-10-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319025585/0000899243-19-025585-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319027503/0000899243-19-027503-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319027504/0000899243-19-027504-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319027506/0000899243-19-027506-index.htm
2019-11-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319027943/0000899243-19-027943-index.htm
2019-12-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924319028358/0000899243-19-028358-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924320006857/0000899243-20-006857-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924320006858/0000899243-20-006858-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924320006859/0000899243-20-006859-index.htm
2020-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924320010047/0000899243-20-010047-index.htm
2020-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924320010048/0000899243-20-010048-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924320010882/0000899243-20-010882-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924320010883/0000899243-20-010883-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924320010884/0000899243-20-010884-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924320010885/0000899243-20-010885-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924320015414/0000899243-20-015414-index.htm
2020-06-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924320015629/0000899243-20-015629-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000089924320015630/0000899243-20-015630-index.htm
2018-09-25DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1751299/000095012318009543/0000950123-18-009543-index.htm
2018-10-26DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1751299/000095012318010255/0000950123-18-010255-index.htm
2018-10-26DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1751299/000095012318010259/0000950123-18-010259-index.htm
2018-11-21DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1751299/000095012318012177/0000950123-18-012177-index.htm
2018-11-21DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1751299/000095012318012178/0000950123-18-012178-index.htm
2019-01-11S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1751299/000119312519007301/0001193125-19-007301-index.htm
2019-01-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1751299/000119312519013095/0001193125-19-013095-index.htm
2019-02-19S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1751299/000119312519043574/0001193125-19-043574-index.htm
2019-02-22S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1751299/000119312519048411/0001193125-19-048411-index.htm
2019-02-22CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1751299/000119312519048424/0001193125-19-048424-index.htm
2019-02-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1751299/000119312519049815/0001193125-19-049815-index.htm
2019-02-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1751299/000119312519049819/0001193125-19-049819-index.htm
2019-02-278-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1751299/000119312519053087/0001193125-19-053087-index.htm
2019-03-01424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1751299/000119312519061191/0001193125-19-061191-index.htm
2019-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000119312519062631/0001193125-19-062631-index.htm
2019-03-06SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1751299/000119312519065480/0001193125-19-065480-index.htm
2019-03-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1751299/000119312519069228/0001193125-19-069228-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000119312519077532/0001193125-19-077532-index.htm
2019-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000119312519099970/0001193125-19-099970-index.htm
2019-07-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000119312519193648/0001193125-19-193648-index.htm
2019-09-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000119312519256139/0001193125-19-256139-index.htm
2019-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000119312519258127/0001193125-19-258127-index.htm
2019-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000119312519279092/0001193125-19-279092-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000119312519286034/0001193125-19-286034-index.htm
2019-12-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000119312519312200/0001193125-19-312200-index.htm
2020-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000119312520000861/0001193125-20-000861-index.htm
2020-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000119312520003012/0001193125-20-003012-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000119312520057853/0001193125-20-057853-index.htm
2020-03-02S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1751299/000119312520058089/0001193125-20-058089-index.htm
2020-03-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1751299/000119312520065096/0001193125-20-065096-index.htm
2020-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000119312520097160/0001193125-20-097160-index.htm
2020-05-08DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1751299/000119312520137024/0001193125-20-137024-index.htm
2020-05-08DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1751299/000119312520137027/0001193125-20-137027-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000119312520137611/0001193125-20-137611-index.htm
2020-05-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1751299/000119312520137617/0001193125-20-137617-index.htm
2020-06-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1751299/000119312520157318/0001193125-20-157318-index.htm
2020-06-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1751299/000119312520159057/0001193125-20-159057-index.htm
2020-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000119312520160739/0001193125-20-160739-index.htm
2020-06-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1751299/000119312520163525/0001193125-20-163525-index.htm
2020-08-04S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1751299/000119312520208865/0001193125-20-208865-index.htm
2020-08-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1751299/000119312520217637/0001193125-20-217637-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000120919120039722/0001209191-20-039722-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000120919120039723/0001209191-20-039723-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000120919120039724/0001209191-20-039724-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000120919120039725/0001209191-20-039725-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000120919120039726/0001209191-20-039726-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000120919120039727/0001209191-20-039727-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000120919120039729/0001209191-20-039729-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000120919120039730/0001209191-20-039730-index.htm
2020-10-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000120919120055206/0001209191-20-055206-index.htm
2020-10-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000120919120055207/0001209191-20-055207-index.htm
2020-10-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000120919120055208/0001209191-20-055208-index.htm
2020-10-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000120919120055209/0001209191-20-055209-index.htm
2020-10-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1751299/000120919120055210/0001209191-20-055210-index.htm
2019-02-27CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1751299/000135445719000096/0001354457-19-000096-index.htm
2020-03-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1751299/000156459020007969/0001564590-20-007969-index.htm
2020-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1751299/000156459020025235/0001564590-20-025235-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000156459020025290/0001564590-20-025290-index.htm
2020-06-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000156459020029545/0001564590-20-029545-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000156459020029794/0001564590-20-029794-index.htm
2020-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000156459020033093/0001564590-20-033093-index.htm
2020-08-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1751299/000156459020035762/0001564590-20-035762-index.htm
2020-08-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000156459020035766/0001564590-20-035766-index.htm
2020-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000156459020045399/0001564590-20-045399-index.htm
2020-10-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000156459020046313/0001564590-20-046313-index.htm
2020-11-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1751299/000156459020049439/0001564590-20-049439-index.htm
2020-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000156459020049445/0001564590-20-049445-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000162828019005628/0001628280-19-005628-index.htm
2019-05-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1751299/000162828019005631/0001628280-19-005631-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000162828019009689/0001628280-19-009689-index.htm
2019-08-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1751299/000162828019009696/0001628280-19-009696-index.htm
2019-10-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1751299/000162828019012816/0001628280-19-012816-index.htm
2019-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1751299/000162828019012820/0001628280-19-012820-index.htm
2019-02-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1751299/999999999519000333/9999999995-19-000333-index.htm
2020-03-10EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1751299/999999999520000538/9999999995-20-000538-index.htm
2020-08-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1751299/999999999520002157/9999999995-20-002157-index.htm
2019-02-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1751299/999999999719000618/9999999997-19-000618-index.htm
2020-01-31SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1751299/999999999720000407/9999999997-20-000407-index.htm
2020-02-04SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1751299/999999999720000447/9999999997-20-000447-index.htm
2020-02-18SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1751299/999999999720000753/9999999997-20-000753-index.htm
2020-02-19SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1751299/999999999720000802/9999999997-20-000802-index.htm

Kaleido Biosciences, Inc (KLDO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kaleido Biosciences, Inc (KLDO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 503%
Institutional Ownership: 7977%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-02-28MICHAEL W BONNEYExecutive ChairBuy68,965.0013.95962,061.751,005,968.00https://www.sec.gov/Archives/edgar/data/1751299/000089924319005964/0000899243-19-005964-index.htm
2019-02-28MICHAEL W BONNEYExecutive ChairBuy2,555.0014.6537,430.751,008,523.00https://www.sec.gov/Archives/edgar/data/1751299/000089924319005964/0000899243-19-005964-index.htm
2020-06-04Flagship Ventures Fund IV General Partner LLC10% Share HolderBuy666,667.007.505,000,002.501,613,778.00https://www.sec.gov/Archives/edgar/data/1751299/000089924320015630/0000899243-20-015630-index.htm
2019-03-04Flagship Ventures Fund V General Partner LLCDirectorBuy333,333.0015.004,999,995.002,244,305.00https://www.sec.gov/Archives/edgar/data/1751299/000089924319006455/0000899243-19-006455-index.htm
2019-03-04Flagship Ventures Fund V General Partner LLCDirectorBuy266,667.0015.004,000,005.002,560,096.00https://www.sec.gov/Archives/edgar/data/1751299/000089924319006455/0000899243-19-006455-index.htm
2020-06-04Flagship Ventures Fund IV General Partner LLC10% Share HolderBuy666,667.007.505,000,002.502,910,972.00https://www.sec.gov/Archives/edgar/data/1751299/000089924320015630/0000899243-20-015630-index.htm
2020-06-04KYRIAZI THEO MELASDirectorBuy33,333.007.50249,997.5033,333.00https://www.sec.gov/Archives/edgar/data/1751299/000089924320015414/0000899243-20-015414-index.htm
2019-03-04Flagship Ventures Fund V General Partner LLCDirectorBuy333,333.0015.004,999,995.006,560,523.00https://www.sec.gov/Archives/edgar/data/1751299/000089924319006455/0000899243-19-006455-index.htm
2020-06-04Flagship Ventures Fund IV General Partner LLC10% Share HolderBuy666,666.007.504,999,995.00666,666.00https://www.sec.gov/Archives/edgar/data/1751299/000089924320015630/0000899243-20-015630-index.htm